Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Placental transfer of the integrase strand inhibitors cabotegravir and bictegravir in the ex-vivo human cotyledon perfusion model
Lucile Pencolé, Minh Patrick Lê, Florian Bouchet-Crivat, et al.
AIDS (2020) Vol. 34, Iss. 14, pp. 2145-2149
Open Access | Times Cited: 19

Showing 19 citing articles:

Long-acting antiretrovirals and HIV treatment adherence
Jean B. Nachega, Kimberly K. Scarsi, Monica Gandhi, et al.
The Lancet HIV (2023) Vol. 10, Iss. 5, pp. e332-e342
Open Access | Times Cited: 50
Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman Living With Human Immunodeficiency Virus
Lena van der Wekken-Pas, Fabian Weiß, Charlotte Simon-Zuber, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 10
Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy
Shakir Atoyebi, Fazila Bunglawala, Nicolas Cottura, et al.
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 8
A review of pharmacokinetic data describing long-acting injectable cabotegravir during pregnancy
Shawnalyn W. Sunagawa, Kimberly K. Scarsi
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic
Zachary Howe, Sarah M. Norman, Abbie F. Lueken, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2021) Vol. 41, Iss. 8, pp. 686-699
Closed Access | Times Cited: 21
Cabotegravir Exposure of Zebrafish (Danio rerio) Embryos Impacts on Neurodevelopment and Behavior
Daniela Zizioli, Isabella Zanella, Luca Mignani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1994-1994
Open Access | Times Cited: 9
HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
Emma G. Foster, Howard E. Gendelman, Aditya N. Bade
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1533-1533
Open Access | Times Cited: 13
Placental transfer and vascular effects of pharmaceutical drugs in the human placenta ex vivo: A review
Hedwig van Hove, Line Mathiesen, Jolien J. M. Freriksen, et al.
Placenta (2022) Vol. 122, pp. 29-45
Open Access | Times Cited: 12
First pharmacokinetic data of bictegravir in pregnant women living with HIV
Vera E. Bukkems, Carmen Hidalgo-Tenorio, Coral García, et al.
AIDS (2021) Vol. 35, Iss. 14, pp. 2405-2406
Closed Access | Times Cited: 15
Second-Generation Human Immunodeficiency Virus Integrase Inhibitors Induce Differentiation Dysregulation and Exert Toxic Effects in Human Embryonic Stem Cell and Mouse Models
Marie-Soleil R Smith, Haneesha Mohan, Abhinav Ajaykumar, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 11, pp. 1992-2001
Open Access | Times Cited: 8
Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors
Emma G. Foster, Nicholas Y. Palermo, Yutong Liu, et al.
Frontiers in Toxicology (2023) Vol. 5
Open Access | Times Cited: 4
3D human tissue models and microphysiological systems for HIV and related comorbidities
Dwight E Yin, Amy Palin, Tania Lombo, et al.
Trends in biotechnology (2023) Vol. 42, Iss. 5, pp. 526-543
Closed Access | Times Cited: 3
Placental transfer of doravirine, a recent HIV-1 NNRTI in the ex vivo human cotyledon perfusion model
Minh Patrick Lê, Lucile Pencolé, Gilles Peytavin, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 76, Iss. 9, pp. 2364-2367
Open Access | Times Cited: 7
Bictegravir pharmacokinetics in a late-presenting HIV-1-infected pregnant woman: a case report
Minh Patrick Lê, Valentine Marie Ferré, Fabienne Mazy, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 77, Iss. 3, pp. 851-853
Closed Access | Times Cited: 6
Considerations for the Use of Long-Acting and Extended-Release Agents During Pregnancy and Lactation
Adeniyi Olagunju, Jyoti S. Mathad, Ahizechukwu C. Eke, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_4, pp. S571-S578
Open Access | Times Cited: 4
A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model
Haneesha Mohan, Kieran Atkinson, Birgit Watson, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1761-1761
Open Access | Times Cited: 3
Translating Clinical Pharmacology Data in Pregnancy to Evidence‐Based Guideline Recommendations: Perspectives From the HIV Field
Kristina M. Brooks, Rachel K. Scott, Brookie M. Best, et al.
The Journal of Clinical Pharmacology (2023) Vol. 63, Iss. S1
Closed Access | Times Cited: 1
The Use of Integrase Strand Transfer Inhibitors to Treat HIV in Pregnancy
Oriel Nissim, Gweneth B. Lazenby
Journal of Midwifery & Women s Health (2021) Vol. 66, Iss. 3, pp. 403-406
Closed Access | Times Cited: 3
Unexpectedly low levels of transplacental transfer of second-generation integrase strand transfer inhibitors bictegravir and cabotegravir
Hugo Soudeyns, Julie B. Dumond
AIDS (2020) Vol. 34, Iss. 14, pp. 2137-2139
Closed Access | Times Cited: 2
Page 1

Scroll to top